(Q38206816)

31 August 2017

title

Benefits of a continuous therapy for cancer patients with a novel adoptive cell therapy by cascade priming (CAPRI). (English)

1 reference

31 August 2017

Rudolf Wank

1

1 reference

31 August 2017

Xin Song

series ordinal

2

1 reference

31 August 2017

Songhai Gu

series ordinal

3

1 reference

31 August 2017

Barbara Laumbacher

series ordinal

4

1 reference

31 August 2017

publication date

1 January 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

6

1 reference

31 August 2017

issue

3

1 reference

31 August 2017

page(s)

269-282

1 reference

Recollections of Dr. Peter Gorer.

31 August 2017

cites work

1 reference

A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS

21 January 2018

1 reference

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer

21 January 2018

1 reference

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

21 January 2018

1 reference

Adoptive cell therapy for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

21 January 2018

1 reference

Cytokine induced killer cells as promising immunotherapy for solid tumors

21 January 2018

1 reference

Cytokine Induced Killer (CIK) cells for the treatment of haematological neoplasms.

21 January 2018

1 reference

Activated monocytes prime naïve T cells against autologous cancer: vigorous cancer destruction in vitro and in vivo

21 January 2018

1 reference

In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma.

21 January 2018

1 reference

Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells

21 January 2018

1 reference

21 January 2018

1 reference

Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602,*301,*0303 alleles

21 January 2018

1 reference

HLA antigens and cervical carcinoma

21 January 2018

1 reference

HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity

21 January 2018

1 reference

The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer

21 January 2018

1 reference

Clonal analysis of cytotoxic T cell response against human melanoma

21 January 2018

1 reference

T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures

21 January 2018

1 reference

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

21 January 2018

1 reference

Immune surveillance of tumors

21 January 2018

1 reference

Detection and quantification of mutations in the plasma of patients with colorectal tumors

21 January 2018

1 reference

Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance

21 January 2018

1 reference

Circulating mutant DNA to assess tumor dynamics

21 January 2018

1 reference

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

21 January 2018

1 reference

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma

21 January 2018

1 reference

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

21 January 2018

1 reference

A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma

21 January 2018

1 reference

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

21 January 2018

1 reference

A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

21 January 2018

1 reference

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

21 January 2018

1 reference

Autoimmunity and tumor immunity induced by immune responses to mutations in self

21 January 2018

1 reference

CD8 lethargy in the absence of CD4 help.

21 January 2018

1 reference

Adoptive immunotherapy of cancer using CD4(+) T cells

21 January 2018

1 reference

On the dynamics of TCR:CD3 complex cell surface expression and downmodulation

21 January 2018

1 reference

Prolongation of life by adoptive cell therapy with cascade primed immune cells in four patients with non-small cell lung cancer stages IIIB and IV and a pancoast tumor: a case series

21 January 2018

1 reference

International, randomized, placebo-controlled, double-blind phase III study of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous non-small-cell lung cancer: MONET1.

21 January 2018

1 reference

Recruiting HLA to fight HIV.

21 January 2018

1 reference

Phagosomes are competent organelles for antigen cross-presentation

21 January 2018

1 reference

Cytokine production and T-cell activation by macrophage-dendritic cells generated for therapeutic use

21 January 2018

1 reference

Strong association between an HLA-DR antigen and thyroid carcinoma

21 January 2018

1 reference

High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.14.6

1 reference

31 August 2017

1 reference